GEST 2018 U.S. accreditation information will be posted shortly. To receive priority updates on GEST 2018 U.S. please click here to join the symposium's mailing list.

GEST 2016 U.S. Learning Objectives

Upon completion of this activity, the learner should be able to:

    · Compare the relative advantages and timing of different endoleak therapies

    · Assess current data for evaluation of upper GI bleeding treated by embolization

    · Determine interventional oncologic therapy decisions based on the latest evidence, established patient care standards and multidisciplinary   approaches.

    · Describe the latest imaging technique that may help in performing intra arterial treatment of liver cancer.

    · Describe the latest options and differences in function, characteristics, and potential outcomes of various devices for embolization.

    · Discuss the new therapeutic options using embolization in hemorrhoid-related bleeding, and chronic shoulder pain.

    · Discuss basic and variant prostate artery anatomy and techniques to identify critical vasculature during therapy.

    · Assess patient symptoms and treatment options for symptomatic benign prostatic hyperplasia, including drug treatment, surgery, and embolization.

    · Explain the indications and results of uterine fibroid and adenomyosis embolization.

    · Summarize the advantages, limitations, technical aspects, and endpoints of various tools and approaches to visceral aneurysm treatment.

 

Target Audience

GEST 2016 U.S. will be of value to interventional radiologists, oncologists, diagnostic radiologists, nurses, radiology technologists, physician assistants, and other healthcare professionals interested in the field of embolization.

CME Accreditation Statement

Complete Conference Management is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Credit Designation Statement

Complete Conference Management designates this live activity for a maximum of 25.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABR/ABS MOC/SAMs sessions credits

Pending approval by the ABR & ABS for self assessment credits towards the Maintenance of Certification program (SAMs).

Thursday, May 5, 2016

Session II: Women's Health

10:30am – noon: 1.5 hours

Friday, May 6, 2016

Session VII: Hepatocellular Carcinoma I & II

1:30 – 3:30pm – 2

Saturday, May 7, 2016

Session VII: Endoleak and Varicoceles

10:30am – noon: 1.5

 

Session XIII: Portal Hypertension and BRTO

8am – 10: 2 hours

Other Credits

ABR MOCs

Qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program.

ABS MOCs

Achieving a score of 75% or more on questions asked during select ISET sessions will allow the AMA PRA Category 1 Credits™ earned during these sessions to count toward self-assessment credits towards Part 2 of the ABS MOC Program.

ANCC

For the purpose of recertification, American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

AANP

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

ARRT

Association for Vascular and Interventional Radiographers (AVIR) ARRT Accreditation. Approved by the AVIR for 25.5 Category A+ CEs

UEMS/EACCME CME Credit Recognition

The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.

Disclaimer

Complete Conference Management makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Disclosure Policy Statement

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Complete Conference Management must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an CCM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

Disclosure of Unlabeled Use

Complete Conference Management requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.